Vaccination strategies to reduce the risk of leukaemia and melanoma

Journal of the Royal Society of Medicine

Volumn 96, Issue 8, 2003, Pages 389-392

  Grange, John M ^a   Stanford, John L ^a   Stanford, Cynthia A ^a   Kölmel, Klaus F ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; DIPHTHERIA VACCINE; TETANUS TOXOID;

ALLERGY; ANTIBODY PRODUCTION; ASTHMA; ATOPY; AUTOIMMUNE DISEASE; BACTERIAL TRANSMISSION; BCG VACCINATION; CANCER PREVENTION; CANCER REGRESSION; CANCER RISK; CARCINOGENESIS; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DIPHTHERIA; ENVIRONMENTAL FACTOR; ERYSIPELAS; GRAVES DISEASE; HAY FEVER; HUMAN; IMMUNE SYSTEM; IMMUNOREGULATION; IMMUNOTHERAPY; INFLUENZA; LEUKEMIA; LIFESTYLE; LUNG TUBERCULOSIS; LYMPHOPROLIFERATIVE DISEASE; MELANOMA; MYCOBACTERIUM TUBERCULOSIS; PASTEURIZATION; REVIEW; SARCOMA; STAPHYLOCOCCUS AUREUS; TETANUS; TETANUS PROPHYLAXIS; TH1 CELL; TH2 CELL; VACCINATION; VIRUS TRANSMISSION;

EID: 0042622529     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1258/jrsm.96.8.389     Document Type: Review

References (33)

1. Stanford JL, Stanford CA, Grange JM. Environmental echoes. Science Progr 2001;84(Pt 2):105-24
2. Martinez FD, Holt PG. Role of microbial burden in aetiology of allergy and asthma. Lancet 1999;354(suppl 2):12-15
3. Bach J-F. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002;347:911-20
4. De Morgan C. Observations on cancer. Lancet 1874;i:323-9
5. Bruns P. Die Heilwirkung des Erysipels auf Geschwulste. Beitr Klin Chir 1887-1888;3:443
6. Coley WB. The treatment of malignant tumors by repeated inoculations of erysipelas. Historical article of 1882, reprinted in Clin Orthop 1991;262:3-11
7. Greaves MF. Aetiology of acute leukaemia. Lancet 1997;349:344-9
8. Perrillat F, Clavel J, Auclerc MF, et al. Day-care, early common infections and childhood acute leukaemia: a multicentre French case-control study. Br J Cancer 2002;86:1064-9
9. Ma X, Buffler PA, Selvin S, et al. Daycare attendance and risk of childhood acute lymphoblastic leukaemia. Br J Cancer 2002;86:1419-24
10. Woolcock AJ, Peat JK. Evidence for the increase in asthma worldwide. Ciba Found Symp 1997;206:122-34
11. Karmaus W, Botezan C. Does a higher number of siblings protect against the development of allergy and asthma? A review. J Epid Commun Hlth 2002;56:209-17
12. Storm van Leeuwen W, Varekamp H. On the tuberculin treatment of bronchial asthma and hay fever. Lancet 1921;ii:1366-9
13. Shirakawa T, Enomoto T, Shimazu S, Hopkin JM. The inverse association between tuberculin response and atopic disorder. Science 1997;275:77-9
14. Grange JM, Stanford JL. The aetiology of childhood leukaemia. Arch Dis Child 1994;70:553-4
15. Grange JM, Stanford JL. BCG vaccination and cancer. Tubercle 1990;71:61-4
16. Skegg DCG. BCG vaccination and the incidence of lymphomas and leukaemia. Int J Cancer 1975;21:18-21
17. Comstock GW. Leukaemia and BCG, a controlled trial. Lancet 1971;ii:1062-3
18. Rosenthal SR. Cancer precursors and their control by BCG. Develop Biol Stand 1986;58:401-16
19. Kristensen I, Aaby P, Jensen H. Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa. BMJ 2000;321:1435-9
20. Pfahlberg A, Kölmel KF, Grange JM, et al. Inverse association between melanoma and previous vaccinations against tuberculosis and smallpox: results of the FEBIM study. J Invest Dermatol 2002;119:570-5
21. Kölmel KF, Pfahlberg A, Mastrangelo G, et al. Infections and melanoma risk: results of a multicentre EORTC case-control study. Melanoma Res 1999;9:511-19
22. Abel U, Becker N, Angerer R, et al. Common infections in the history of cancer patients and controls. J Cancer Res Clin Oncol 1991;117:339-44
23. Albonico HU, Bräker HU, Hüsler J. Febrile infectious childhood diseases in the history of cancer patients and matched controls. Med Hypoth 1998;51:315-20
24. Holt PG. Potential role of environmental factors in the etiology and pathogenesis of atopy: a working model. Environ Health Perspect 1999;107(suppl 3):485-7
25. Rook GA, Stanford JL. Give us this day our daily germs. Immunol Today 1998;19:113-16
26. Stanford JL, Stanford CA, Baban B, Grange JM. Therapeutic vaccination for cancer: the potential value of mycobacterial products. Int J Pharmaceut Med 1999;12:191-5
27. Marchent A, Goetghebeur T, Ota MO, et al. Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guérin vaccination. J Immunol 1999;163:2249-55
28. Kaempfer R, Gerez L, Farbstein H, et al. Prediction of response to treatment in superficial bladder carcinoma through pattern of interleukin-2 gene expression. J Clin Oncol 1996;14:1778-86
29. Maraveyas A, Baban B, Kennard D, et al. Possible improved survival of patients with stage IV AJCC melanoma receiving SRL 172 immunotherapy: correlation with induction of increased levels of intracellular interleukin-2 in peripheral blood leucocytes. Ann Oncol 1999;10:817-24
30. Eriksson NE, Holmén A, Högstedt B, Mikoczy Z, Hagmar L. A prospective study of cancer incidence in a cohort examined for allergy. Allergy 1995;50:718-22
31. Kölmel KF, Compagnone D. Melanom und Atopie. Deutsche Med Wochenschr 1988;113:169-71
32. Broberg A, Augustsson A. Atopic dermatitis and melanocytic naevi. Br J Dermatol 2000;142:306-9
33. Grange JM, Stanford JL, Stanford CA. Campbell De Morgan's 'Observations on cancer', and their relevance today. J R Soc Med 2002;95:296-9